PTIE - Pain Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
3.835
-0.225 (-5.542%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.060
Open4.022
Bid3.790 x 1000
Ask25.000 x 2200
Day's Range3.790 - 4.060
52 Week Range3.100 - 9.310
Volume49,331
Avg. Volume39,892
Market Cap25.29M
Beta1.27
PE Ratio (TTM)-1.91
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2012-12-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • Healthcare Industry Trends And Its Impact On Pain Therapeutics Inc (PTIE)
    Simply Wall St.2 days ago

    Healthcare Industry Trends And Its Impact On Pain Therapeutics Inc (PTIE)

    Pain Therapeutics Inc (NASDAQ:PTIE), a USD$26.78M small-cap, operates in the healthcare industry, which continues to endure a more demanding healthcare agenda, and the global need for innovative, cost-effective medicines continuesRead More...

  • How Should You Think About Pain Therapeutics Inc’s (PTIE) Risks?
    Simply Wall St.17 days ago

    How Should You Think About Pain Therapeutics Inc’s (PTIE) Risks?

    If you are a shareholder in Pain Therapeutics Inc’s (NASDAQ:PTIE), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • Associated Press2 months ago

    Pain Therapeutics reports 2Q loss

    On a per-share basis, the Austin, Texas-based company said it had a loss of 64 cents. The company's shares closed at $3.38. A year ago, they were trading at $18.23. _____ This story was generated by Automated ...

  • Associated Press6 months ago

    Pain Therapeutics reports 1Q loss

    The Austin, Texas-based company said it had a loss of 6 cents per share. In the final minutes of trading on Tuesday, the company's shares hit 80 cents. A year ago, they were trading at $2.55. _____ This ...

  • Investopedia7 months ago

    Pain Therapeutics’ Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT)

    Following the positive update, Pain Therapeutics stock spiked by around 61% to hit $1.10 per share during after hours trading on Monday.

  • Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means
    Insider Monkey8 months ago

    Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means

    Pain Therapeutics, Inc. (NASDAQ:PTIE) put out a fourth-quarter business update, and alongside it, gave us some insight into the possible future of the company’s long suffering abuse deterrent asset, Remoxy. This is one that we have covered in the past on a number of occasions here Market Exclusive, yet one that remains on an as-yet […]

  • Associated Press8 months ago

    Pain Therapeutics reports 4Q loss

    The Austin, Texas-based company said it had a loss of 6 cents per share. For the year, the company reported a loss of $14.9 million, or 33 cents per share, swinging to a loss in the period. The company's ...

  • Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers?
    Insider Monkey10 months ago

    Pain Therapeutics, Inc. (PTIE): How Does It Compare Against Its Peers?

    A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]

  • Zacks Small Cap Researchlast year

    Durect (DRRX) Exited Third Quarter with Strong Balance Sheet

    By Grant Zeng, CFA NASDAQ:DRRX Durect Exited Third Quarter with Strong Balance Sheet On October 31, Durect (NASDAQ:DRRX) announced its financial results for the third quarter of 2016 ended September 30. ...